image

The best stocks to buy since 1993

Latest issue now available

BTG - Refocussing as an old-fashioned biotech

June 2005

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BGC
  • Price:
  • 150p
The shares are up a little this month following the group's results for the year to 31 March.  Revenues which derived from various products marketed by other companies were slightly ahead at £42.6m and pretax loss was £34.3m, of which £12.6m was mainly restructuring costs.  Net cash at the year end amounted to £34.4m, which the group believes is adequate to execute its strategy. Under a new chief executive, Louise Makin, who joined last October, BTG will now intensify its focus on acquiring life science technologies (two thirds of its 50-odd technologies already fall into this category). As a consequence it is making further modest cost savings, including subletting surplus office space in Central London ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe